The global cosmetic surgery and procedure market size was estimated to be USD 64.78 billion in 2023 and is expected to reach at USD 191.2 billion by 2033 with a CAGR of 10.34% during the forecast period 2023-2033. Rising fitness-conscious desire to look young, growing introduction of technologically advanced products, surge in demand for minimally invasive & non-invasive procedures, increasing awareness regarding cosmetic surgery, rising popularity of aesthetic treatment for facial enhancement, growing launch of innovative aesthetic devices, and surge in approvals of innovative devices by regulatory bodies are some of the key factors boosting the market growth.
Surge in approvals of innovative aesthetic devices by regulatory bodies is predicted to boost the market growth during the forecast period. For instance, in January 2022, Lumenis has introduced the Splendor X device to the United Kingdom market. The device is CE cleared and offers treatments for hair removal, vascular conditions, pigmented lesions, and wrinkles.
By Procedure, Invasive was the highest revenue-grossing segment in the global cosmetic surgery and procedure market in 2022 owing to the surge in number of breast augmentation & liposuction procedures and growing in number of approvals for cosmetic surgeries by regulatory bodies. Additionally, non-invasive is predicted to grow at fastest CAGR during the forecast period owing to the rising applications associated with the procedure such as less pain, instant results, & low cost, increasing focus on physical appearance, growing awareness regarding medical aesthetic procedures, and surge in launch of new products. For instance, in July 2021, Allergan has disclosed that the U.S. Food and Drug Administration (FDA) granted approval for an expanded label of BOTOX®. The label now includes eight additional muscles for treating upper limb spasticity in adults. The newly added muscles comprise those in the elbow and forearm, specifically the brachialis, brachioradialis, pronator teres, and pronator quadratus.
By Gender, Female was the highest revenue-grossing segment in the global cosmetic surgery and procedure market in 2022 owing to the surge in demand for breast augmentation procedures, increasing emphasis on personal aesthetics among women, and growing number of female populations conducting cosmetic surgery, and rising approvals by regulatory bodies. For instance, in March 2022, Health Canada has granted regulatory approval to Sientra breast implants. The company has partnered with Kai Aesthetic, its local partner, to market the breast implants in Canada. Sientra is committed to maintaining the highest standards of product quality, safety, and service for both patients and plastic surgeons, as per the distribution agreement. Additionally, Male is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of obesity among male population, increasing fitness-conscious desire to look young, and surge in number of males undergoing procedures such as liposuction & eyelid surgeries.
By Age Group, 30-54 was the highest revenue-grossing segment in the global cosmetic surgery and procedure market in 2022 owing to the surge in demand for liposuction and growing number of cosmetic procedures among age group of 30 to 54. Additionally, 13-29 is predicted to grow at fastest CAGR during the forecast period owing to the growing focus on physical appearance among young generation, growing demand for non-invasive & aesthetic procedures, and rising approvals by regulatory bodies. For instance, in June 2020, The FDA has granted approval to Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), for the use of JUVÉDERM® VOLUMA™ XC in adults over 21 years of age to augment the chin region.
By End-user, Hospital & clinic was the highest revenue-grossing segment in the global cosmetic surgery and procedure market in 2022 owing to the surge in cosmetic surgeries and growing number of hospitals & clinics to conduct various surgical procedures. Additionally, Cosmetic surgical centre is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare infrastructure, growing adoption of advanced technologies for cosmetic surgeries, and increasing introduction of advanced devices. For instance, in June 2022, Cynosure has introduced the PicoSure Pro device as the latest enhancement to the PicoSure platform. This device stands out as the sole FDA-cleared 755nm picosecond laser available, delivering energy in a trillionth of a second through pressure instead of heat. As a result, it offers secure and efficient treatments for unwanted pigmentation and skin revitalization suitable for all skin types.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing healthcare infrastructure, growing adoption of cosmetic procedures, rising prevalence of skin disorders, surge in breast augmentation procedures, increasing adoption of novel cosmetic treatments, and growing focus on expansion & new product launch by major market players. For instance, in August 2020, The formation of Revance Therapeutics, Inc.'s field force, which will launch the introduction of its prestige aesthetics portfolio in the United States, has been announced. The portfolio includes the RHA Collection of dermal fillers, which features resilient hyaluronic acid, as well as the HintMD financial technology platform. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising adoption of technologically advanced products, increasing focus on physical appearance, surge in healthcare expenditures, and growing launch of innovative products. For instance, in August 2022, Juvéderm VOLUX has been formally introduced in India by Allergan Healthcare India Private Limited's business unit, Allergan Aesthetics. Before the product launch in India, Allergan Aesthetics secured all the required approvals from the Central Drugs Standards Control Organization (CDSCO) office.
Surge in approvals of innovative aesthetic devices by regulatory bodies is predicted to boost the market growth during the forecast period. For instance, in January 2022, Lumenis has introduced the Splendor X device to the United Kingdom market. The device is CE cleared and offers treatments for hair removal, vascular conditions, pigmented lesions, and wrinkles.
By Procedure, Invasive was the highest revenue-grossing segment in the global cosmetic surgery and procedure market in 2022 owing to the surge in number of breast augmentation & liposuction procedures and growing in number of approvals for cosmetic surgeries by regulatory bodies. Additionally, non-invasive is predicted to grow at fastest CAGR during the forecast period owing to the rising applications associated with the procedure such as less pain, instant results, & low cost, increasing focus on physical appearance, growing awareness regarding medical aesthetic procedures, and surge in launch of new products. For instance, in July 2021, Allergan has disclosed that the U.S. Food and Drug Administration (FDA) granted approval for an expanded label of BOTOX®. The label now includes eight additional muscles for treating upper limb spasticity in adults. The newly added muscles comprise those in the elbow and forearm, specifically the brachialis, brachioradialis, pronator teres, and pronator quadratus.
By Gender, Female was the highest revenue-grossing segment in the global cosmetic surgery and procedure market in 2022 owing to the surge in demand for breast augmentation procedures, increasing emphasis on personal aesthetics among women, and growing number of female populations conducting cosmetic surgery, and rising approvals by regulatory bodies. For instance, in March 2022, Health Canada has granted regulatory approval to Sientra breast implants. The company has partnered with Kai Aesthetic, its local partner, to market the breast implants in Canada. Sientra is committed to maintaining the highest standards of product quality, safety, and service for both patients and plastic surgeons, as per the distribution agreement. Additionally, Male is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of obesity among male population, increasing fitness-conscious desire to look young, and surge in number of males undergoing procedures such as liposuction & eyelid surgeries.
By Age Group, 30-54 was the highest revenue-grossing segment in the global cosmetic surgery and procedure market in 2022 owing to the surge in demand for liposuction and growing number of cosmetic procedures among age group of 30 to 54. Additionally, 13-29 is predicted to grow at fastest CAGR during the forecast period owing to the growing focus on physical appearance among young generation, growing demand for non-invasive & aesthetic procedures, and rising approvals by regulatory bodies. For instance, in June 2020, The FDA has granted approval to Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), for the use of JUVÉDERM® VOLUMA™ XC in adults over 21 years of age to augment the chin region.
By End-user, Hospital & clinic was the highest revenue-grossing segment in the global cosmetic surgery and procedure market in 2022 owing to the surge in cosmetic surgeries and growing number of hospitals & clinics to conduct various surgical procedures. Additionally, Cosmetic surgical centre is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare infrastructure, growing adoption of advanced technologies for cosmetic surgeries, and increasing introduction of advanced devices. For instance, in June 2022, Cynosure has introduced the PicoSure Pro device as the latest enhancement to the PicoSure platform. This device stands out as the sole FDA-cleared 755nm picosecond laser available, delivering energy in a trillionth of a second through pressure instead of heat. As a result, it offers secure and efficient treatments for unwanted pigmentation and skin revitalization suitable for all skin types.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing healthcare infrastructure, growing adoption of cosmetic procedures, rising prevalence of skin disorders, surge in breast augmentation procedures, increasing adoption of novel cosmetic treatments, and growing focus on expansion & new product launch by major market players. For instance, in August 2020, The formation of Revance Therapeutics, Inc.'s field force, which will launch the introduction of its prestige aesthetics portfolio in the United States, has been announced. The portfolio includes the RHA Collection of dermal fillers, which features resilient hyaluronic acid, as well as the HintMD financial technology platform. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising adoption of technologically advanced products, increasing focus on physical appearance, surge in healthcare expenditures, and growing launch of innovative products. For instance, in August 2022, Juvéderm VOLUX has been formally introduced in India by Allergan Healthcare India Private Limited's business unit, Allergan Aesthetics. Before the product launch in India, Allergan Aesthetics secured all the required approvals from the Central Drugs Standards Control Organization (CDSCO) office.
Segmentation: Cosmetic Surgery And Procedure Market Report 2022 - 2033
Cosmetic Surgery And Procedure Market Analysis & Forecast by Procedure 2022 - 2033 (Revenue USD Bn)
Non-invasive
- Dermal Fillers
- Botox Injections
- Laser Hair Removal
- Microdermabrasion
- Chemical Peel
- Others
Invasive
- Liposuction
- Breast Augmentation
- Nose Reshaping
- Tummy Tuck
- Eyelid Surgery
- Others
Cosmetic Surgery And Procedure Market Analysis & Forecast by Gender 2022 - 2033 (Revenue USD Bn)
- Male
- Female
Cosmetic Surgery And Procedure Market Analysis & Forecast by Age Group 2022 - 2033 (Revenue USD Bn)
- 13-29
- 30-54
- 55 and above
Cosmetic Surgery And Procedure Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Hospital & Clinic
- Cosmetic Surgical Centre
- Ambulatory Surgical Facility
Cosmetic Surgery And Procedure Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Cosmetic Surgery And Procedure Market: Procedure Estimates & Trend Analysis
8. Cosmetic Surgery And Procedure Market: Gender Estimates & Trend Analysis
9. Cosmetic Surgery And Procedure Market: Age Group Estimates & Trend Analysis
10. Cosmetic Surgery And Procedure Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Cosmetic Surgery And Procedure Market
13. Europe Global Cosmetic Surgery And Procedure Market
14. Asia Pacific Global Cosmetic Surgery And Procedure Market
15. Latin America Global Cosmetic Surgery And Procedure Market
16. MEA Global Cosmetic Surgery And Procedure Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Sientra Inc
- AbbVie Inc.
- Candela Syneron
- Cynosure Inc.
- Teoxane Laboratories
- Evolus Inc.
- Johnson and Johnson
- RevanceGalderma
- Merz Pharma GmbH and Co. KGaA
- Lumenis
- Bausch Health Companies Inc.
- Solta Medical
- Sinclair Pharmaceuticals Limited
- Syneron Candela
- Galderma SA
- Alma Laser
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 64.78 Billion |
| Forecasted Market Value ( USD | $ 191.2 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
